PHBI
Pharmagreen Biotech Inc.Company Information
- Company Name
- Pharmagreen Biotech Inc.
- CIK
- CIK0001435181
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PHBI: OTC
- Fiscal Year End
- September 30
- Owner Organization
- Not Available
- SIC
- 4581
- SIC Description
- Airports, Flying Fields & Airport Terminal Services
- Ticker
- PHBI
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2023-08-14
- Price on filing date
- —
- 1-month reaction
- -40.74%
- 3-month reaction
- -74.07%
Balance Sheet
Values in millions ($)| Line item | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2020-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
| Cash | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts And Other Receivables Net Current | - | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets | - | - | 0 | - | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
Assets Current | |||||||||||||||||
| Assets Current | 0 | 0 | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | - | - | 0 | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Notes And Loans Receivable Net Current | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Liabilities | |||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Loans Payable Current | - | - | 0 | - | - | 0 | 0 | - | 0 | 0 | 0 | ||||||
Liabilities Current | |||||||||||||||||
| Liabilities Current | 2 | 2 | 2 | - | 3 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Loans Payable | 0 | 0 | - | - | 0 | 0 | 0 | - | - | 0 | - | ||||||
| Convertible Notes Payable Current | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Derivative Asset Fair Value Gross Liability | - | - | 0 | - | 1 | 0 | 0 | 0 | - | 1 | - | ||||||
| Derivative Liabilities Current | 0 | 0 | - | - | - | - | - | - | 0 | 1 | 2 | ||||||
| Due To Related Parties Noncurrent | - | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Other Loans Payable Current | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Long Term Loans Payable | - | - | 0 | - | 0 | - | 0 | - | - | 0 | - | ||||||
| Notes Payable Related Parties Noncurrent | - | - | 0 | - | - | - | 0 | - | - | - | - | ||||||
| Convertible Long Term Notes Payable | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Due To Related Parties Current | - | 0 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Convertible Subordinated Debt | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 2 | 2 | 2 | - | 3 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
Equity | |||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | - | 0 | 10 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Subscriptions | - | - | 0 | - | - | - | 0 | - | - | - | - | ||||||
Stockholders Equity | |||||||||||||||||
| Stockholders Equity | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -3 | -2 | ||||||
| Additional Paid In Capital | 10 | 10 | 10 | - | 10 | 0 | 10 | 9 | 9 | 4 | 4 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | - | -0 | -0 | -0 | -0 | -0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -13 | -13 | -13 | - | -13 | -12 | -12 | -11 | -11 | -7 | -6 | ||||||
| Minority Interest | -0 | -0 | -0 | - | -0 | 0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
Organization Consolidation And Presentation Of Financial Statements | |||||||||||||||||
| Debt Instrument Unamortized Discount Current | - | - | 0 | - | - | - | 0 | 0 | - | 0 | 0 | ||||||
| Debt Instrument Unamortized Discount Noncurrent | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Subordinated Debt Current | 0 | 0 | - | - | 0 | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,000 | 2,000 | 2,000 | - | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 500 | ||||||
| Common Stock Shares Issued | 464 | 455 | 442 | - | 397 | 385 | 381 | 355 | 348 | 96 | 91 | ||||||
| Shares Outstanding | 464 | 455 | 442 | - | 397 | 385 | 381 | 355 | 348 | 96 | 91 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPharmagreen Biotech Inc. (PHBI) — SEC Financial Statements & Analysis
Pharmagreen Biotech Inc. (PHBI) is a airports, flying fields & airport terminal services company, incorporated in NV. Pharmagreen Biotech Inc. trades on OTC as: PHBI. Pharmagreen Biotech Inc. (PHBI)'s most recent SEC filing is a Form 10-Q for the period ended 2023-06-30, filed with the SEC on 2023-08-14. Based on that filing, On profitability, Pharmagreen Biotech Inc. posts an operating margin of 644.29%, a net margin of -34620.77%, a Return on Equity (ROE) of 26.72%, and a Return on Assets (ROA) of -384.91%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -73.18% year-over-year and EPS growth of -76.50% year-over-year. On the balance sheet, it maintains a current ratio of 0.02x, a quick ratio of 0.00x, working capital of $-2.12M, a debt-to-equity ratio of -1.07x, a debt ratio of 16.33, an interest coverage ratio of -6.01x, free cash flow of $-138.51K (TTM), and net debt of $145.29K. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.00
- ROE TTM
- 26.72%
- ROA TTM
- -384.91%
- Debt To Equity
- -1.07x
- Free Cash Flow TTM
- $-138.51K
Data as of 2023-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Pharmagreen Biotech Inc. in?
Pharmagreen Biotech Inc. (PHBI) operates in the Airports, Flying Fields & Airport Terminal Services industry.
What exchange does PHBI trade on?
Pharmagreen Biotech Inc. (PHBI) trades on the OTC.
Where is Pharmagreen Biotech Inc. incorporated?
Pharmagreen Biotech Inc. is incorporated in NV.
When was Pharmagreen Biotech Inc. (PHBI)'s most recent SEC filing?
Pharmagreen Biotech Inc. (PHBI)'s most recent SEC filing is a Form 10-Q for the period ended 2023-06-30, filed with the SEC on 2023-08-14.
What is PHBI's EPS (earnings per share)?
Pharmagreen Biotech Inc. (PHBI)'s trailing twelve month EPS is $-0.00 as of 2023-06-30.
What is PHBI's ROE (return on equity)?
Pharmagreen Biotech Inc. (PHBI)'s trailing twelve month Return on Equity (ROE) is 26.72% as of 2023-06-30.
What is PHBI's ROA (return on assets)?
Pharmagreen Biotech Inc. (PHBI)'s trailing twelve month Return on Assets (ROA) is -384.91% as of 2023-06-30.